Education
Bachelor of Science, Bucknell University. Doctor of Philosophy in Pharmacology, Rutgers University.
Bachelor of Science, Bucknell University. Doctor of Philosophy in Pharmacology, Rutgers University.
Molecular pharmacologist, Neuroscience Group Abbott Laboratories, 1986—1989. Various positions, inclduing senior vice president, research Affymax Research Institute (acquired by Glaxo Welcome plc, now known as GlaxoSmithKline), Palo Alto, California, 1989—1999. Co-founder, board directors XenoPort, Inc., since 1999, chief science officer, 1999—2001, Chief Executive Officer, since 2001.